The ability to specifically interfere with the function of proteins of path
ological significance has been a goal for molecular medicine for many years
. Peptide aptamers comprise a new class of molecules., with a peptide moiet
y of randomized sequence, which are selected for their ability to bind to a
given target protein under intracellular conditions. They have the potenti
al to inhibit the biochemical activities of a target protein, can delineate
the interactions of the target protein in regulatory networks, and identif
y novel therapeutic targets. Peptide aptamers represent a new basis for dru
g design and protein therapy, with implications for basic and applied resea
rch, for a broad variety of different types of diseases. (C) 2001 Elsevier
Science Ltd. All rights reserved.